DI BELLA METHOD > DOCUMENTATION INDEX > MDB - Documents

 
 
MDB - Documents
 
 
Synthesis and preliminary evaluation of Tc-99m-labeled somatostatin analog (RC-160) using "3+1" mixed ligand approach. (30/05/2003)
Detail
Somatostatin and somatostatin analogues in medullary thyroid carcinoma. (30/05/2003)
Detail
Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. (30/05/2003)
Detail
Somatostatin and cancer. (30/05/2003)
Detail
Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. (30/05/2003)
Detail
Duodenal somatostatinoma of the ampulla of vater diagnosed by endoscopic fine needle aspiration biopsy: a case report. (30/05/2003)
Detail
Duodenal somatostatinoma and erythrocytosis in a patient with von Hippel-Lindau disease type 2A. (30/05/2003)
Detail
Suppression of mammary-derived growth inhibitor gene expression by growth hormone and insulin-like growth factor I. (30/05/2003)
Detail
[A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer] (30/05/2003)
Detail
A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma. (30/05/2003)
Detail
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. (30/05/2003)
Detail
The current status of somatostatin receptors in malignant melanoma. (30/05/2003)
Detail
Somatostatin receptor status in non-medullary thyroid carcinoma] (30/05/2003)
Detail
Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastoma cells. (30/05/2003)
Detail
Drug-targeting strategies in cancer therapy. (30/05/2003)
Detail
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 |
 
 

Stampa